Showing 701 - 720 results of 856 for search '"Myocardial infarction"', query time: 0.09s Refine Results
  1. 701

    Hydroxytyrosol Protects against Myocardial Ischemia/Reperfusion Injury through a PI3K/Akt-Dependent Mechanism by Ying-hao Pei, Jiao Chen, Liang Xie, Xiao-min Cai, Run-Hua Yang, Xing Wang, Jian-bin Gong

    Published 2016-01-01
    “…The rats were randomized into five groups: sham group, I/R group, HT+I/R group, HT+LY294002+I/R group, and LY+I/R group. Myocardial infarct size, markers of oxidative stress, extent of myocardial apoptosis, echocardiographically assessed cardiac function, and expression of Akt and GSK 3β were measured in each group. …”
    Get full text
    Article
  2. 702

    Lights and Siren Transport and the Need for Hospital Intervention in Nontrauma Patients: A Prospective Study by Olivier Bertholet, Mathieu Pasquier, Elina Christes, Damien Wirths, Pierre-Nicolas Carron, Olivier Hugli, Fabrice Dami

    Published 2020-01-01
    “…Since 2013, rapid transportation from the field, fast-track, is currently used for patients with acute ST-elevation myocardial infarction, suspicion of acute stroke and out-of-hospital cardiac arrest. …”
    Get full text
    Article
  3. 703

    M2 Macrophages as a Potential Target for Antiatherosclerosis Treatment by Ying Bi, Jixiang Chen, Feng Hu, Jing Liu, Man Li, Lei Zhao

    Published 2019-01-01
    “…Atherosclerosis is a chronic progressive inflammation course, which could induce life-threatening diseases such as stroke and myocardial infarction. Optimal medical treatments for atherosclerotic risk factors with current antihypertensive and lipid-lowering drugs (for example, statins) are widely used in clinical practice. …”
    Get full text
    Article
  4. 704

    Percutaneous Intervention or Bypass Graft for Left Main Coronary Artery Disease? A Systematic Review and Meta-Analysis by Waqas Ullah, Yasar Sattar, Irfan Ullah, Ammu Susheela, Maryam Mukhtar, M. Chadi Alraies, Mamas A. Mamas, David L. Fischman

    Published 2020-01-01
    “…There was no significant difference in the rate of myocardial infarction (MI) (p = 0.17) and revascularization (p = 0.12). …”
    Get full text
    Article
  5. 705

    Robotic-assisted left thoracic small-incision minimally invasive coronary artery bypass grafting: a case series report by HE Peiling, SONG Yi, YUAN Ye

    Published 2025-01-01
    “…All of them experienced angina pectoris, and 1 had a history of myocardial infarction, 1 had dilated cardiomyopathy, 2 patients had chronic obstructive pulmonary disease (COPD), and 10 had a history of percutaneous coronary intervention (PCI). …”
    Get full text
    Article
  6. 706

    Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Stu... by Annunziata Nusca, Angelo Lauria Pantano, Rosetta Melfi, Claudio Proscia, Ernesto Maddaloni, Rocco Contuzzi, Fabio Mangiacapra, Andrea Palermo, Silvia Manfrini, Paolo Pozzilli, Germano Di Sciascio

    Published 2015-01-01
    “…Moreover, GV, and predominantly hypoglycemic variations, has been observed to increase in patients with periprocedural myocardial infarction. Thus, our study investigated the usefulness of CGM in the setting of PCI where an optimal glycemic control should be achieved in order to prevent complications and improve outcome.…”
    Get full text
    Article
  7. 707

    Electronegative LDL from Rabbits Fed with Atherogenic Diet Is Highly Proinflammatory by Po-Yuan Chang, Jou-Hsiang Pai, Yu-Sheng Lai, Shao-Chun Lu

    Published 2019-01-01
    “…Electronegative low-density lipoprotein (LDL(-)) has been found in the plasma of familial hypercholesterolemia and acute myocardial infarction and has been implicated in atherosclerosis and cardiovascular disease. …”
    Get full text
    Article
  8. 708

    Examining the Outcomes of Hybrid Coronary Revascularization in Acute STEMI Patients from 2015 to 2022 by Mozhgan Bahramian, Seyed Ali Moezi bady, Maryam Bahramian, Ahmad Amouzeshi

    Published 2024-01-01
    “…Considering the newness of this treatment method and the limitations of previous studies, we investigated the results of staged HCR in acute ST-elevation myocardial infarction (STEMI) patients in this study. Methods. …”
    Get full text
    Article
  9. 709

    Prognostic and diagnostic accuracy of intracoronary electrocardiogram recorded during percutaneous coronary intervention: a meta-analysis by Jun Fan, Weijie Li, Yizhi Pan, Jialin He, Jiankai Huang, Pingan Chen

    Published 2022-06-01
    “…The pooled ORs with 95% CIs of ST-segment elevation recorded by IC-ECG were 4.65 (1.69 to 12.77), 5.08 (1.10 to 23.44), 4.53 (0.79 to 25.90) and 1.83 (0.93 to 3.62) for major adverse cardiac events, myocardial infarction, cardiac death and revascularisation, respectively. …”
    Get full text
    Article
  10. 710

    Beneficial Effects of Long-Term Administration of an Oral Formulation of Angiotensin-(1–7) in Infarcted Rats by Fúlvia D. Marques, Marcos B. Melo, Leandro E. Souza, Maria Claúdia C. Irigoyen, Rúben D. Sinisterra, Frederico B. de Sousa, Sílvia Q. Savergnini, Vinícius B. A. Braga, Anderson J. Ferreira, Robson A. S. Santos

    Published 2012-01-01
    “…In this study was evaluated the chronic cardiac effects of a formulation developed by including angiotensin(Ang)-(1–7) in hydroxypropyl β-cyclodextrin (HPβCD), in infarcted rats. Myocardial infarction (MI) was induced by left coronary artery occlusion. …”
    Get full text
    Article
  11. 711

    Recurrence of atrial fibrillation and late cardiovascular events in patients with persistent atrial fibrillation after restoration of sinus rhythm by U.P. Chernyaha-Royko, N.S. Pavlyk, M.S. Sorokivskyy, A.V. Aker, O.J. Zharinov

    Published 2020-06-01
    “…During 9-month follow-up, 15 (12.5 %) of 120 patients developed cardiovascular events: death (n = 1), stroke (n = 2), other thromboischemic events (n = 3), myocardial infarction (n = 1), decompensated heart failure (n = 4) and left ventricular ejection fraction (LVEF) reduction 10 % or more (n = 9). …”
    Get full text
    Article
  12. 712

    Exacerbation of Glycoprotein VI-Dependent Platelet Responses in a Rhesus Monkey Model of Type 1 Diabetes by J. F. Arthur, Y. Shen, Y. Chen, J. Qiao, R. Ni, Y. Lu, R. K. Andrews, E. E. Gardiner, J. Cheng

    Published 2013-01-01
    “…Platelet reactivity is crucial to thrombus formation, particularly in arterial vessels and in thrombotic complications causing myocardial infarction or ischaemic stroke, but diabetic patients often respond poorly to current antiplatelet medication. …”
    Get full text
    Article
  13. 713

    Endothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular Disease by Caterina Oriana Aragona, Egidio Imbalzano, Federica Mamone, Valentina Cairo, Alberto Lo Gullo, Angela D’Ascola, Maria Adriana Sardo, Michele Scuruchi, Giorgio Basile, Antonino Saitta, Giuseppe Mandraffino

    Published 2016-01-01
    “…MEDLINE was searched using keywords related to “endothelial progenitor cells” and “endothelium” and, for the different categories, respectively, “smoking”; “blood pressure”; “diabetes mellitus” or “insulin resistance”; “dyslipidemia”; “aging” or “elderly”; “angina pectoris” or “myocardial infarction”; “stroke” or “cerebrovascular disease”; “homocysteine”; “C-reactive protein”; “vitamin D”. …”
    Get full text
    Article
  14. 714

    Syndecan-1: A Review on Its Role in Heart Failure and Chronic Liver Disease Patients’ Assessment by Radu-Stefan Miftode, Ionela-Lăcrămioara Şerban, Amalia-Stefana Timpau, Ionela-Larisa Miftode, Adriana Ion, Ana-Maria Buburuz, Alexandru-Dan Costache, Irina-Iuliana Costache

    Published 2019-01-01
    “…Multiple evidence revealed that syndecan-1 is also associated with tissue injury and may regulate inflammatory and regenerative responses, being considered a protective molecule that limits the inflammation and reduces cardiac remodelling and dysfunction after a myocardial infarction. Syndecan-1 may also be used as a reliable biomarker for the noninvasive assessment of liver fibrosis. …”
    Get full text
    Article
  15. 715
  16. 716

    Stentless Strategy by Drug-Coated Balloon Angioplasty following Directional Coronary Atherectomy for Left Main Bifurcation Lesion by Norihiro Kobayashi, Masahiro Yamawaki, Shinsuke Mori, Masakazu Tsutsumi, Yohsuke Honda, Kenji Makino, Shigemitsu Shirai, Masafumi Mizusawa, Yoshiaki Ito

    Published 2021-01-01
    “…There was no cardiac death, no myocardial infarction, no coronary artery bypass grafting, and no bleeding complications at 12 months. …”
    Get full text
    Article
  17. 717

    ClimaWATCH: A new interactive tool for community heat-health vulnerability assessments by Aparna Keshaviah, Dheeya Rizmie, Huihua Lu, Mike Rudacille, Eric Morris, Colleen Psomas, Farid Qamar, Xindi C. Hu

    Published 2025-01-01
    “…Nationally in 2020, excess Medicaid spending amounted to $18 million on heat stress, $15 million on electrolyte imbalance, $25 million on acute myocardial infarction, and $133 million on acute renal failure. …”
    Get full text
    Article
  18. 718

    CircHIPK2 recruits SRSF1 to increase TXNIP mRNA stability and promotes autophagy-dependent ferroptosis and apoptosis in myocardial ischemia-reperfusion injury by Zhu Zhang, Jinqi Hao, Qinghong Qiao, Junting Song, Yanqin Yu

    Published 2025-02-01
    “…Abstract Background Myocardial ischemia/reperfusion injury (MIRI) secondary to acute myocardial infarction (AMI) can lead to cardiomyocyte death and impaired cardiac function. …”
    Get full text
    Article
  19. 719

    Impact of multimorbidity on long-term outcomes in older adults with non-ST elevation acute coronary syndrome in the North East of England: a multi-centre cohort study of patients u... by Chris Wilkinson, Vijay Kunadian, Benjamin Beska, Abdulla A Damluji, Hanna Ratcovich, Greg B Mills

    Published 2022-07-01
    “…The primary composite outcome was all-cause mortality, myocardial infarction, stroke, urgent repeat revascularisation or significant bleeding.Results Mean age was 80.9 (±6.1) years. …”
    Get full text
    Article
  20. 720

    Long term cost-effectiveness analysis of IDegLira in the treatment of type 2 diabetes patients compared to GLP-1RA added to basal insulin after IDegLira entered the national reimbu... by Dunming Xiao, Junling Weng, Lei Zhang, Chang Xing, Yan Wei, Yingyao Chen

    Published 2025-01-01
    “…Ischemic heart disease, heart failure, and myocardial infarction (stroke) decreased by 0.8%, 1.1%, and 4.7%, respectively. …”
    Get full text
    Article